[Progress in diagnosis of and therapy for diabetic polyneuropathies].
Baba
Masayuki
M
D000125:Achilles Tendon / Q000503:physiopathology; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D003937:Diagnosis, Differential; D004568:Electrodiagnosis; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007649:Ketamine / Q000627:therapeutic use; D009431:Neural Conduction; D012021:Reflex, Abnormal; D014732:Vibration; D014805:Vitamin B 12 / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D004791:Enzyme Inhibitors; D018691:Excitatory Amino Acid Antagonists; D007004:Hypoglycemic Agents; D007649:Ketamine; D000449:Aldehyde Reductase; D014805:Vitamin B 12